These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9296233)
1. Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus. Morgan AS; Brennan PJ; Fishman NO Ann Pharmacother; 1997 Sep; 31(9):970-3. PubMed ID: 9296233 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment. Thomas AR; Cieslak PR; Strausbaugh LJ; Fleming DW Infect Control Hosp Epidemiol; 2002 Nov; 23(11):683-8. PubMed ID: 12452297 [TBL] [Abstract][Full Text] [Related]
3. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Anglim AM; Klym B; Byers KE; Scheld WM; Farr BM Arch Intern Med; 1997 May; 157(10):1132-6. PubMed ID: 9164379 [TBL] [Abstract][Full Text] [Related]
4. Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium. Belliveau PP; Rothman AL; Maday CE Am J Health Syst Pharm; 1996 Jul; 53(13):1570-5. PubMed ID: 8809278 [TBL] [Abstract][Full Text] [Related]
5. Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection. Miller M; Bernard L; Thompson M; Grima D; Pepin J Infect Control Hosp Epidemiol; 2010 Jul; 31(7):710-5. PubMed ID: 20518636 [TBL] [Abstract][Full Text] [Related]
6. Comparative cost-effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia. McComb MN; Collins CD Pharmacotherapy; 2014 Jun; 34(6):537-44. PubMed ID: 24390863 [TBL] [Abstract][Full Text] [Related]
7. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Lai KK; Kelley AL; Melvin ZS; Belliveau PP; Fontecchio SA Infect Control Hosp Epidemiol; 1998 Sep; 19(9):647-52. PubMed ID: 9778162 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre. Shaikh ZH; Osting CA; Hanna HA; Arbuckle RB; Tarr JJ; Raad II J Hosp Infect; 2002 May; 51(1):52-8. PubMed ID: 12009821 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology and control of vancomycin-resistant enterococci in an adult and children's hospital. Tucci V; Haran MA; Isenberg HD Am J Infect Control; 1997 Oct; 25(5):371-6. PubMed ID: 9343618 [TBL] [Abstract][Full Text] [Related]
16. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Bhorade SM; Christenson J; Pohlman AS; Arnow PM; Hall JB Chest; 1999 Apr; 115(4):1085-91. PubMed ID: 10208212 [TBL] [Abstract][Full Text] [Related]
17. Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile. Salgado CD; Giannetta ET; Farr BM Infect Control Hosp Epidemiol; 2004 May; 25(5):413-7. PubMed ID: 15188848 [TBL] [Abstract][Full Text] [Related]
18. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan. Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639 [TBL] [Abstract][Full Text] [Related]
19. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Lautenbach E; Bilker WB; Brennan PJ Infect Control Hosp Epidemiol; 1999 May; 20(5):318-23. PubMed ID: 10349947 [TBL] [Abstract][Full Text] [Related]
20. Vancomycin-resistant enterococcal infections in Korea. Kim JM; Song YG Yonsei Med J; 1998 Dec; 39(6):562-8. PubMed ID: 10097684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]